209 related articles for article (PubMed ID: 27714644)
21. Optimal Lymphadenectomy in Small Bowel Neuroendocrine Tumors: Analysis of the NCDB.
Motz BM; Lorimer PD; Boselli D; Hill JS; Salo JC
J Gastrointest Surg; 2018 Jan; 22(1):117-123. PubMed ID: 28819895
[TBL] [Abstract][Full Text] [Related]
22. Mesenteric Lymphadenectomy in Well-Differentiated Appendiceal Neuroendocrine Tumors.
Raoof M; Dumitra S; O'Leary MP; Singh G; Fong Y; Lee B
Dis Colon Rectum; 2017 Jul; 60(7):674-681. PubMed ID: 28594716
[TBL] [Abstract][Full Text] [Related]
23. Analysis of lymph node metastasis in pancreatic neuroendocrine tumors (PNETs) based on the tumor size and hormonal production.
Tsutsumi K; Ohtsuka T; Mori Y; Fujino M; Yasui T; Aishima S; Takahata S; Nakamura M; Ito T; Tanaka M
J Gastroenterol; 2012 Jun; 47(6):678-85. PubMed ID: 22350698
[TBL] [Abstract][Full Text] [Related]
24. Significance of lymph node metastasis in pancreatic neuroendocrine tumor.
Taki K; Hashimoto D; Nakagawa S; Ozaki N; Tomiyasu S; Ohmuraya M; Arima K; Kaida T; Higashi T; Sakamoto K; Sakata K; Okabe H; Nitta H; Hayashi H; Chikamoto A; Beppu T; Takamori H; Hirota M; Baba H
Surg Today; 2017 Sep; 47(9):1104-1110. PubMed ID: 28229300
[TBL] [Abstract][Full Text] [Related]
25. Revisiting the concept of lymph node metastases of pancreatic head cancer: number of metastatic lymph nodes and lymph node ratio according to N stage.
Kang MJ; Jang JY; Chang YR; Kwon W; Jung W; Kim SW
Ann Surg Oncol; 2014 May; 21(5):1545-51. PubMed ID: 24419758
[TBL] [Abstract][Full Text] [Related]
26. Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study Group.
Lopez-Aguiar AG; Zaidi MY; Beal EW; Dillhoff M; Cannon JGD; Poultsides GA; Kanji ZS; Rocha FG; Marincola Smith P; Idrees K; Beems M; Cho CS; Fisher AV; Weber SM; Krasnick BA; Fields RC; Cardona K; Maithel SK
Ann Surg Oncol; 2019 Aug; 26(8):2517-2524. PubMed ID: 31004295
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant radiotherapy and lymph node status for pancreatic cancer: results of a study from the Surveillance, Epidemiology, and End Results (SEER) Registry Data.
Opfermann KJ; Wahlquist AE; Garrett-Mayer E; Shridhar R; Cannick L; Marshall DT
Am J Clin Oncol; 2014 Apr; 37(2):112-6. PubMed ID: 23211221
[TBL] [Abstract][Full Text] [Related]
28. Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma.
Malleo G; Maggino L; Nobile S; Casciani F; Cacciatori N; Paiella S; Luchini C; Rusev B; Capelli P; Marchegiani G; Bassi C; Salvia R
Eur J Surg Oncol; 2020 Sep; 46(9):1734-1741. PubMed ID: 32327367
[TBL] [Abstract][Full Text] [Related]
29. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
[TBL] [Abstract][Full Text] [Related]
30. Lymph Node Metastatic Patterns and Survival Predictors Based on Tumor Size in Pancreatic Ductal Adenocarcinoma.
Pu N; Chen Q; Gan W; Shen Y; Gao S; Habib JR; Yin H; Zhang J; Kinny-Köster B; Cui M; Li J; Dong Y; Nagai M; Liu L; Yu J; Wu W; Lou W
Adv Ther; 2021 Aug; 38(8):4258-4270. PubMed ID: 34176089
[TBL] [Abstract][Full Text] [Related]
31. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.
Slidell MB; Chang DC; Cameron JL; Wolfgang C; Herman JM; Schulick RD; Choti MA; Pawlik TM
Ann Surg Oncol; 2008 Jan; 15(1):165-74. PubMed ID: 17896141
[TBL] [Abstract][Full Text] [Related]
32. The eighth version of American Joint Committee on Cancer nodal classification for high grade pancreatic neuroendocrine tumor should be generalized for the whole population with this disease.
Li MX; Wang HY; Yuan CH; Ma CL; Jiang B; Li L; Zhang L; Zhao H; Cai JQ; Xiu DR
Medicine (Baltimore); 2020 Sep; 99(37):e22089. PubMed ID: 32925749
[TBL] [Abstract][Full Text] [Related]
33. Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors.
Sohn B; Kwon Y; Ryoo SB; Song I; Kwon YH; Lee DW; Moon SH; Park JW; Jeong SY; Park KJ
J Gastrointest Surg; 2017 Dec; 21(12):2066-2074. PubMed ID: 29047070
[TBL] [Abstract][Full Text] [Related]
34. Regional Metastatic Behavior of Nonfunctional Pancreatic Neuroendocrine Tumors: Impact of Lymph Node Positivity on Survival.
Jutric Z; Grendar J; Hoen HM; Cho SW; Cassera MA; Newell PH; Hammill CW; Hansen PD; Wolf RF
Pancreas; 2017 Aug; 46(7):898-903. PubMed ID: 28697130
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic index of lymphadenectomy among patients with pancreatic neuroendocrine tumors: A multi-institutional analysis.
Wu L; Sahara K; Tsilimigras DI; Maithel SK; Poultsides GA; Rocha FG; Weber SM; Fields RC; Idrees K; Cho CS; Shen F; Pawlik TM;
J Surg Oncol; 2019 Dec; 120(7):1080-1086. PubMed ID: 31468550
[TBL] [Abstract][Full Text] [Related]
36. The role of inguinal lymph node dissection in men with urethral squamous cell carcinoma.
Werntz RP; Riedinger CB; Fantus RJ; Smith ZL; Packiam VT; Adamsky MA; Smith N; Steinberg GD
Urol Oncol; 2018 Dec; 36(12):526.e1-526.e6. PubMed ID: 30446445
[TBL] [Abstract][Full Text] [Related]
37. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
Wang J; Li J; Chen R; Lu X
Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
[TBL] [Abstract][Full Text] [Related]
38. [Analysis of risk factors and prognosis of No.8p lymph node metastasis in cases with advanced gastric cancer].
Chen L; Wei S; Ye Z; Zeng Y; Zheng Q; Xiao J; Wang Y; Zhuo C; Lin Z; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Feb; 20(2):218-223. PubMed ID: 28226359
[TBL] [Abstract][Full Text] [Related]
39. Predictors of lymph node metastases and impact on survival in resected pancreatic neuroendocrine tumors: a single-center experience.
Wong J; Fulp WJ; Strosberg JR; Kvols LK; Centeno BA; Hodul PJ
Am J Surg; 2014 Nov; 208(5):775-780. PubMed ID: 24997491
[TBL] [Abstract][Full Text] [Related]
40. Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.
Mao R; Zhao H; Li K; Luo S; Turner M; Cai JQ; Blazer D
Ann Surg Oncol; 2019 Sep; 26(9):2722-2729. PubMed ID: 31209670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
